Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
318
-
Total 13F shares, excl. options
-
33M
-
Shares change
-
+1.53M
-
Total reported value, excl. options
-
$3.25B
-
Value change
-
+$158M
-
Put/Call ratio
-
31.42
-
Number of buys
-
195
-
Number of sells
-
-129
-
Price
-
$98.39
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q2 2025
387 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q2 2025.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 318 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33M shares
.
Largest 10 shareholders include BlackRock, Inc. (3.35M shares), VANGUARD GROUP INC (3.04M shares), Pentwater Capital Management LP (1.72M shares), FIL Ltd (1.31M shares), ALPINE ASSOCIATES MANAGEMENT INC. (1.1M shares), STATE STREET CORP (1.07M shares), NORGES BANK (902K shares), UBS Group AG (879K shares), TIG Advisors, LLC (857K shares), and Qube Research & Technologies Ltd (791K shares).
This table shows the top 318 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.